FAQ: What to Know About the DEA’s CBD Rescheduling Order

For the first time ever, the Drug Enforcement Agency this week removed a cannabis-derived drug from Schedule I of the Controlled Substances Act. The change is a historic landmark on the path to ending cannabis prohibition, but it’s not nearly as sweeping as it might seem. RELATED STORY US Reschedules CBD Drug—but Not CBD Itself […]

US Reschedules CBD Drug—but Not CBD Itself

Roughly three months after the Food and Drug Administration approved the cannabis-derived pharmaceutical Epidiolex for the treatment of epilepsy disorders, the US government has officially rescheduled drugs that contain CBD—but only if they’ve already been greenlighted by the FDA. “Any other CBD product other than Epidiolex remains a Schedule I controlled substance.” Rusty Payne, DEA […]

Terpinolene: The Least-Common Common Terpene

The cannabis plant is an impressive alchemist, capable of producing hundreds of cannabinoids and terpenes. Some, such as THC and CBD, are widely known outside the cannabis community. Others, including terpenes like the woodsy alpha-pinene and the citrusy limonene, are just entering the mainstream cannabis lexicon, helping consumers understand what gives cannabis its distinctive taste […]

Live from Boston Freedom Rally: A Smokin’ Hot Party on the Common

Welcome to Leafly’s live 4/20 coverage of the 2018 Boston Freedom Rally. News Editor Ben Adlin is roaming Boston Common all weekend, and he’ll be updating our coverage of news, events, performances, and random weird stuff he sees. Check back often, it’s gonna be wicked fun. BOSTON — The East Coast’s largest cannabis festival kicked […]

1 2 3 4
Right Menu Icon